rs2229319

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000246.4(CIITA):​c.1973C>G​(p.Ala658Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,613,500 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A658A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0089 ( 27 hom., cov: 32)
Exomes 𝑓: 0.00087 ( 21 hom. )

Consequence

CIITA
NM_000246.4 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.19

Publications

4 publications found
Variant links:
Genes affected
CIITA (HGNC:7067): (class II major histocompatibility complex transactivator) This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
CIITA Gene-Disease associations (from GenCC):
  • MHC class II deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040816665).
BP6
Variant 16-10907465-C-G is Benign according to our data. Variant chr16-10907465-C-G is described in ClinVar as Benign. ClinVar VariationId is 317701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00887 (1351/152302) while in subpopulation AFR AF = 0.0305 (1269/41576). AF 95% confidence interval is 0.0291. There are 27 homozygotes in GnomAd4. There are 610 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 27 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000246.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CIITA
NM_000246.4
MANE Select
c.1973C>Gp.Ala658Gly
missense
Exon 11 of 20NP_000237.2
CIITA
NM_001286402.1
c.1976C>Gp.Ala659Gly
missense
Exon 11 of 20NP_001273331.1
CIITA
NM_001379332.1
c.1976C>Gp.Ala659Gly
missense
Exon 11 of 20NP_001366261.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CIITA
ENST00000324288.14
TSL:1 MANE Select
c.1973C>Gp.Ala658Gly
missense
Exon 11 of 20ENSP00000316328.8
CIITA
ENST00000573309.5
TSL:1
n.1944C>G
non_coding_transcript_exon
Exon 10 of 10
CIITA
ENST00000381835.9
TSL:1
c.860-1518C>G
intron
N/AENSP00000371257.5

Frequencies

GnomAD3 genomes
AF:
0.00882
AC:
1343
AN:
152184
Hom.:
27
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0304
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00379
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00230
AC:
566
AN:
245560
AF XY:
0.00163
show subpopulations
Gnomad AFR exome
AF:
0.0320
Gnomad AMR exome
AF:
0.00180
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000547
Gnomad OTH exome
AF:
0.000994
GnomAD4 exome
AF:
0.000872
AC:
1274
AN:
1461198
Hom.:
21
Cov.:
67
AF XY:
0.000772
AC XY:
561
AN XY:
726898
show subpopulations
African (AFR)
AF:
0.0302
AC:
1010
AN:
33478
American (AMR)
AF:
0.00201
AC:
90
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52884
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111900
Other (OTH)
AF:
0.00214
AC:
129
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
93
186
280
373
466
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00887
AC:
1351
AN:
152302
Hom.:
27
Cov.:
32
AF XY:
0.00819
AC XY:
610
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0305
AC:
1269
AN:
41576
American (AMR)
AF:
0.00379
AC:
58
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68020
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00268
Hom.:
3
Bravo
AF:
0.0102
ESP6500AA
AF:
0.0251
AC:
110
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.00286
AC:
347
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
MHC class II deficiency (3)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
9.3
DANN
Benign
0.50
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-0.90
T
PhyloP100
-1.2
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.12
Sift
Benign
0.34
T
Sift4G
Benign
0.098
T
Vest4
0.18
MVP
0.55
MPC
0.18
ClinPred
0.014
T
GERP RS
-10
gMVP
0.31
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229319; hg19: chr16-11001322; COSMIC: COSV99048281; COSMIC: COSV99048281; API